Scanning Disparities
Whether lung cancer patients receive PET scans depends on race, according to a study.
Progress Against Cancer
Whether lung cancer patients receive PET scans depends on race, according to a study.
Research on premalignancy is needed to fully tap the potential of cancer interception.
Researchers estimate that breast cancer surpassed lung cancer as the most commonly diagnosed cancer globally in 2020, and more news of the week from Cancer Today.
When creating anything new, one must ask the question, “will others use it?” A driving force behind the creation of AACR Project GENIE (Genomics Evidence Neoplasia Information Exchange) was to create an open access...
Esophageal adenocarcinoma increasingly found in adults under 50, study finds
The FDA has expanded the approval of a molecularly targeted therapeutic to treat certain pediatric and adult patients with medullary thyroid cancer. The U.S. Food and Drug Administration has approved pralsetinib (Gavreto) to treat certain adult and pediatric patients age...
Several options are available for the treatment of breast cancer, including local therapies such as surgery and radiation therapy, as well as systemic therapies such as chemotherapy, hormone therapy, targeted therapy, and immunotherapy. While...
The pandemic may make cancer clinical trials more patient-centric, and more news of the week from Cancer Today.
A study indicates that some breast cancer patients who receive mastectomy and reconstruction may be at risk of persistent drug use following surgery.
Study finds adherence to follow-up screening guidelines is low among people at high risk of developing lung cancer, and more news of the week from Cancer Today.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More